-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Corvus Pharmaceuticals, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2014 to 2023.
- Corvus Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$4.26M, a 34.5% increase year-over-year.
- Corvus Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$22.6M, a 42% increase year-over-year.
- Corvus Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$27M, a 34.6% increase from 2022.
- Corvus Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$41.3M, a 4.47% increase from 2021.
- Corvus Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$43.2M, a 621% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)